chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Decreased appetite, Dizziness, Fatigue, Irregular sleep phase
Clinical narrative: Nauseous; Muscle pain; No appetite; Most painful on shot arm; Crash naps 3 times on first day; Vision disruption; Chest pain; Dizzy; Pain in lymph under armpitsand neck; Exhaustion all day; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch number: ER 2613), via an unspecified route of administration, administered in arm left on 23Mar2021 at 10:00 as a single dose (at the age of vaccination 42-years) for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch number: ER 6205), via an unspecified route of administration, administered at left arm on 02Mar2021 at 10:00 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was allergic to keflex, bractrum. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the most recent dose of COVID-19 vaccine in a clinic. On 23Mar2021, the patient experienced vision disruption, dizzy non-stop for first 4 hrs that impacted vision and stability, pain in lymph under armpits and neck, most painful on shot arm, crash naps 3 times on first day, exhaustion all day, no appetite, nauseous. muscle pain and chest pain for 3 days. The patient did not receive any therapeutic measures for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events most painful on shot arm, dizzy, crash naps 3 times on first day, exhaustion, nauseous, pain in lymph, vision disruption and no appetite were recovering. The clinical outcome of the events muscle pain and chest pain was recovered on unknown date. No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Myalgia, Nausea, Vaccination site pain, Visual impairment
Clinical narrative: Nauseous; Muscle pain; No appetite; Most painful on shot arm; Crash naps 3 times on first day; Vision disruption; Chest pain; Dizzy; Pain in lymph under armpitsand neck; Exhaustion all day; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch number: ER 2613), via an unspecified route of administration, administered in arm left on 23Mar2021 at 10:00 as a single dose (at the age of vaccination 42-years) for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch number: ER 6205), via an unspecified route of administration, administered at left arm on 02Mar2021 at 10:00 as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was allergic to keflex, bractrum. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the most recent dose of COVID-19 vaccine in a clinic. On 23Mar2021, the patient experienced vision disruption, dizzy non-stop for first 4 hrs that impacted vision and stability, pain in lymph under armpits and neck, most painful on shot arm, crash naps 3 times on first day, exhaustion all day, no appetite, nauseous. muscle pain and chest pain for 3 days. The patient did not receive any therapeutic measures for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events most painful on shot arm, dizzy, crash naps 3 times on first day, exhaustion, nauseous, pain in lymph, vision disruption and no appetite were recovering. The clinical outcome of the events muscle pain and chest pain was recovered on unknown date. No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Pyrexia
Clinical narrative: Body ache; Fever; Headache; This is a spontaneous report received from a non-contactable consumer, the patient. A 32-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 32-years-old), as a single dose for COVID-19 immunisation. The patient had no any medical history. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any concomitant medications within two weeks of vaccine. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. On an unknown date in Mar2021, the patient experienced fever, headache and body pain. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fever, headache and general body pain was resolving.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Cognitive disorder, Fatigue, Feeling abnormal, Restlessness, Somnolence
Clinical narrative: Intense fatigue; Losing train of thought mid sentence frequently, forgetting questions right after theyre asked; slow cognitive function; Sleeping for several hours at time; Brain fog days after injection; Not feeling rested; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP6955), via an unspecified route of administration in the left arm on 18Mar2021 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Medical history included GERD, pernicious anemia, migraine and seasonal allergies. The patient did not have any allergies to medications, food, or other products. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN), levomilnacipran hydrochloride (FETZIMA), nasal allergy spray (MANUFACTURER UNKNOWN) and famotidine (PEPCID); all from an unknown date and for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021, the patient experienced intense fatigue and brain fog days after injection; sleeping for several hours at a time but not feeling rested; losing train of thought in mid sentence frequently, forgetting questions right after they were asked; slow cognitive function. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of the events fatigue extreme, foggy feeling in head, sleepy, restlessness and cognitive function abnormal were not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Pain in extremity
Clinical narrative: Pain in the outer arm where the shot was given; Pain under the arm of the arm/in the armpit area where the shot was administered; Fatigue; This is a spontaneous report received from a non-contactable patient. A 40-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via unspecified route of administration on right arm on 23Mar2021 at 10:30 (at the age of 40-year-old) as a single dose, for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Prior to vaccination the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Mar2021, the patient experienced pain in the outer arm where the shot was given (pain in arm), pain under the arm of the arm/in the armpit area where the shot was administered (armpit pain) and fatigue. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events pain in arm, armpit pain and fatigue were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: High fever of 102.8; Chills; Aches; Swollen lymph nodes under arm ofshot; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via an unspecified route of administration in the left arm on 22Mar2021 at 09:00 as a single dose (at the age of 41-years-old) for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to penicillin. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via unspecified route of administration in the left arm on 01Mar2021 at 09:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medications within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021 at 21:00, the patient had experienced, high fever of (102.8), chills, aches and had swollen lymph node under arm of shot. Th patient did not receive treatment for the reported events. The clinical outcome of the events high fever of 102.8, chills, aches and swollen lymph node under arm of shot was resolved on an unspecified date in Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node over collar bone; This is a spontaneous report received from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 17Mar2021 at 14:15 hours (at the age of 58-years) as a single dose for COVID-19 immunisation. Medical history included chronic inflammation and COVID-19 from an unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any allergies to medications, food, or other products. Concomitant medications included low dose naltrexone (MANUFACTURER UNKNOWN) and esomeprazole magnesium (NEXIUM) received medications in two weeks. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccination. On 20Mar2021 at 08:00 hours, the patient experienced swollen lymph node over the collar bone. The events did not result in doctor or other healthcare professional office/clinic visits, and the emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event swollen lymph nodes was resolving at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore arm; headache; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EN5318), via an unspecified route of administration in the left arm on 23Mar2021 at 13:45 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Concomitant medications included calcium (MANUFACTURER UNKNOWN), multivitamin supplements (MANUFACTURER UNKNOWN), ibuprofen (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EN5318), via an unspecified route of administration in the left arm on 02Mar2021 at 08:00 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021 at 12:00, the patient experienced sore arm and headache. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore arm and headache was recovered on unspecified date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Back pain, Chills, Facial pain, Feeding disorder
Clinical narrative: Stomach ache (very minimal); could not eat the entire day; change in taste; Chills; headache; Terrible back ache; stabbing feeling in my left cheekbone; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic lyme and bartonella (bartonellosis). The patient had no known allergies. The patient received doxycycline (MANUFACTURER UNKNOWN), ceftriaxone sodium (ROCEPHIN) and unspecified herbal anti-inflammatories (MANUFACTURER UNKNOWN) within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 04Mar2021 at 10:00 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 01:00 (15 hours after the second dose), the patient woke up in the middle of the night with chills, headache, terrible back ache and a stabbing feeling in the left cheekbone and change in taste. On 25Mar2021 at 09:00 (next day), the patient had stomach ache and could not eat the entire day. The patient did not receive any treatment for these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, headache, terrible back ache, could not eat the entire day and stabbing feeling in left cheekbone was resolved on 25Mar2021 at 21:00 (all symptoms resolved), whereas for events stomach ache (very minimal) and change in taste was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Taste disorder
Clinical narrative: Stomach ache (very minimal); could not eat the entire day; change in taste; Chills; headache; Terrible back ache; stabbing feeling in my left cheekbone; This is a spontaneous report received from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247), via an unspecified route of administration in the left arm on 23Mar2021 at 10:00 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic lyme and bartonella (bartonellosis). The patient had no known allergies. The patient received doxycycline (MANUFACTURER UNKNOWN), ceftriaxone sodium (ROCEPHIN) and unspecified herbal anti-inflammatories (MANUFACTURER UNKNOWN) within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 04Mar2021 at 10:00 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 01:00 (15 hours after the second dose), the patient woke up in the middle of the night with chills, headache, terrible back ache and a stabbing feeling in the left cheekbone and change in taste. On 25Mar2021 at 09:00 (next day), the patient had stomach ache and could not eat the entire day. The patient did not receive any treatment for these events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, headache, terrible back ache, could not eat the entire day and stabbing feeling in left cheekbone was resolved on 25Mar2021 at 21:00 (all symptoms resolved), whereas for events stomach ache (very minimal) and change in taste was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Malaise, Nausea, Vomiting
Clinical narrative: Head fogginess; tiredness; feeling unwell; Nausea; light vomiting; This is a spontaneous report from a non-contactable consumer, the patient. A 24-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ERB727), via unspecified route of administration, at left arm on 25Mar2021 at 9:00 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. The patient medical history included anxiety, depression, asthma. Concomitant therapy included venlafaxine hydrochloride (EFFEXOR), doxycycline (MANUFACTURER UNKNOWN), cetirizine hydrochloride (ZYRTEC) for unknown indication. The patient was not allergic to medications, foods or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 11:00 (within 2 hours of vaccine), the patient experienced head fogginess, tiredness and feeling unwell whereas, she experienced nausea and vomiting later on (as reported). No therapeutic measures were taken for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events head fogginess, tiredness, feeling unwell, nausea and vomiting were resolved on unknown date in Mar2021.   No follow-up attempts are needed. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dizziness, Fatigue, Nausea, Nightmare
Clinical narrative: Dizziness/heart palpitations all over 5 full days with waves of dizziness being the strongest; Nausea; Fatigue; restlessness; anxiety; sleep deprivation; strong and scary dreams; Heart palpitations all over 5 full days; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6206), via an unspecified route of administration in the left arm on an unspecified date in Mar2021 at 13:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included shellfish allergy. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On an unspecified date in Mar2021, the patient experienced dizziness, nausea, fatigue, restlessness, anxiety, sleep deprivation, strong and scary dreams, heart palpitations all over 5 full days with waves of dizziness being the strongest. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events dizziness, nausea, fatigue, restlessness, anxiety, sleep deprivation, bad dreams, palpitations was recovered with sequelae.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Restlessness, Sleep deficit
Clinical narrative: Dizziness/heart palpitations all over 5 full days with waves of dizziness being the strongest; Nausea; Fatigue; restlessness; anxiety; sleep deprivation; strong and scary dreams; Heart palpitations all over 5 full days; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6206), via an unspecified route of administration in the left arm on an unspecified date in Mar2021 at 13:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included shellfish allergy. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On an unspecified date in Mar2021, the patient experienced dizziness, nausea, fatigue, restlessness, anxiety, sleep deprivation, strong and scary dreams, heart palpitations all over 5 full days with waves of dizziness being the strongest. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. The clinical outcome of the events dizziness, nausea, fatigue, restlessness, anxiety, sleep deprivation, bad dreams, palpitations was recovered with sequelae.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood pressure increased, Heart rate increased
Clinical narrative: Fast heart rate; Increased blood pressure; Had anxiety on my skin; This is a spontaneous report from a contactable nurse, the patient. A 30-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EP6955) via an unspecified route of administration in the left arm on 22Mar2021 at 12:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications were not reported. The patient had known allergies to shellfish. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient was not tested for COVID-19. On 22Mar2021 at 23:30, the patient experienced fast heart rate and increased blood pressure. It was reported that the patient felt as if she had anxiety on her skin. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The reported adverse events were treated with propranolol(UNKNOWN MANUFACTURER) 20mg as a therapeutic measure. The clinical outcome of the reported events fast heart rate, increased blood pressure and anxiety was recovering at the time of this report.    No follow-up attempts possible. No further information expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in ears; This is a spontaneous report from a non-contactable consumer, the patient. A 64-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EJ1686) via unspecified route of administration on 21Jan2021 at (at the age of 64-years-old) as a single dose for COVID-19 immunisation and received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via unspecified route of administration on 11Feb2021 at (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were reported as no. There were no known allergies reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested for COVID-19 since the vaccination. The patient had not received any other vaccines within four weeks prior to the vaccination. On 23Jan2021, the patient experienced ringing in ears. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had not received any treatment for the events. The clinical outcome of the event ringing in ears was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Pyrexia
Clinical narrative: chills; fever; fatigue; joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 58-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via unspecified route of administration in the right arm on 23Mar2021 at 12:00 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included arthritis and diabetes. The patient had a history of known allergies to amoxicillin, septra ds and penicillin.  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021, the patient experienced chills, fever, fatigue and joint pain. The patient did not receive any treatment for the reported events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of chills, fever, fatigue and joint pain was resolved on Mar2021.   No follow-up attempts are possible. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Headache, Pyrexia
Clinical narrative: Headache; fever (101.2); arthralgia; fatigue; This is a spontaneous report from a contactable consumer, the parent. A 23-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ep7534) via an unspecified route of administration on 23Mar2021 in the left arm (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and migraine. The patient had known allergies with avocado and strawberries. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number en6205) via an unspecified route of administration on 02Mar2021 in the left arm (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021, the patient experienced headache, fever (101.2), arthralgia and fatigue. The patient lab test included body temperature which was measured on 24Mar2021 and the result was 101.2 (unspecified units). The patient received acetaminophen as treatment medication for the events headache, fever (101.2), arthralgia and fatigue. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of headache, fever, arthralgia and fatigue was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Somnolence
Clinical narrative: Extreme tiredness; grogginess; body felt lightweight too.; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ep7534) via an unspecified route of administration on an unknown date in Mar2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On an unknown date in Mar2021 (the day after vaccination), the patient experienced extreme tiredness, grogginess and the body felt lightweight too. The clinical outcome of events extreme tiredness, grogginess and body felt lightweight were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Migraine, Myalgia, Swollen tongue
Clinical narrative: Tongue swelling; Tight chest; Wheezing; Very tired; Migraine; Worsemuscles hurt; This is a spontaneous report from a contactable consumer, the patient. A 57-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6208) via an unspecified route of administration in the left arm on 24Mar2021 at 01:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, migraine, fibromyalgia, pseudotumor cerebri, arthritis and the patient was allergic to latex, sting, PCN and fruit. Concomitant medications included tizanidine (MANUFRATURER UNKNOWN), erenumab (AIMOVIG), famotidine (MANUFRATURER UNKNOWN), pregabalin(LYRICA) and hydromorphone hydrochloride (DILAUDID), all were from unknown date and for unspecified indication. The patient previously received thimerosol (MANUFRATURER UNKNOWN), naproxen (MANUFRATURER UNKNOWN), promethazine, penicillin (MANUFRATURER UNKNOWN), prochlorperazine malate (MANUFRATURER UNKNOWN), droperidol (MANUFRATURER UNKNOWN), codeine (MANUFRATURER UNKNOWN) , acetazolamide (DIAMOX), povidone iodine (MANUFRATURER UNKNOWN) , ceftazidime (MANUFRATURER UNKNOWN), trimethobenzamide (MANUFRATURER UNKNOWN) , buprenorphone; naloxone (SUBOXONE), cefuroxime (ZINACEF), methadone (MANUFRATURER UNKNOWN) and polymyxin topical (MANUFRATURER UNKNOWN), all on unknown date and for unspecified indication and patient experienced drug allergy. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine.  On 25Mar2021 at 02:00, the patient experienced tongue swelling, minor tight chest, wheezing, very tired, migraine and worse muscles hurt. The patient did not receive any treatment for adverse event. The clinical outcome of the events tongue swelling, minor tight chest, wheezing, very tired, migraine and worse muscles hurt was recovered on unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Tongue swelling; Tight chest; Wheezing; Very tired; Migraine; Worsemuscles hurt; This is a spontaneous report from a contactable consumer, the patient. A 57-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: EN6208) via an unspecified route of administration in the left arm on 24Mar2021 at 01:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, migraine, fibromyalgia, pseudotumor cerebri, arthritis and the patient was allergic to latex, sting, PCN and fruit. Concomitant medications included tizanidine (MANUFRATURER UNKNOWN), erenumab (AIMOVIG), famotidine (MANUFRATURER UNKNOWN), pregabalin(LYRICA) and hydromorphone hydrochloride (DILAUDID), all were from unknown date and for unspecified indication. The patient previously received thimerosol (MANUFRATURER UNKNOWN), naproxen (MANUFRATURER UNKNOWN), promethazine, penicillin (MANUFRATURER UNKNOWN), prochlorperazine malate (MANUFRATURER UNKNOWN), droperidol (MANUFRATURER UNKNOWN), codeine (MANUFRATURER UNKNOWN) , acetazolamide (DIAMOX), povidone iodine (MANUFRATURER UNKNOWN) , ceftazidime (MANUFRATURER UNKNOWN), trimethobenzamide (MANUFRATURER UNKNOWN) , buprenorphone; naloxone (SUBOXONE), cefuroxime (ZINACEF), methadone (MANUFRATURER UNKNOWN) and polymyxin topical (MANUFRATURER UNKNOWN), all on unknown date and for unspecified indication and patient experienced drug allergy. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine.  On 25Mar2021 at 02:00, the patient experienced tongue swelling, minor tight chest, wheezing, very tired, migraine and worse muscles hurt. The patient did not receive any treatment for adverse event. The clinical outcome of the events tongue swelling, minor tight chest, wheezing, very tired, migraine and worse muscles hurt was recovered on unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Pain, Skin discolouration
Clinical narrative: Black and blue mark on left side of neck.; Aches and pains through shoulders and back.; pains through shoulders and back.; pains through shoulders and back; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL3248) via an unspecified route of administration on left arm on 24Mar2021 at 09:45 (at the age of 38 years old) as a single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. The patients known allergies were reported as no. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 25Mar2021, the patient started to experience black and blue marks on the left sides of his neck, aches and pains through shoulders and back. No therapeutic measures were taken for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events black and blue mark on the left sides of his neck, aches and pains through shoulders and back was recovering at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Energy increased, Headache, Insomnia, Neck pain
Clinical narrative: not slept; headache; neck ache; energy bursts; This is a spontaneous report from a contactable nurse. A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration at left arm on 12Mar2021 at 12:15 hours (at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history of the patient was reported as sensitivity to latex. Concomitant medication was not taken by the patient. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 12Mar2021 the patient experienced events energy bursts first in her left arm, then left torso, then lower left leg, lower right leg, right torso and right arm. On 12Mar2021 at 20:00, the patient experienced events headache and neck ache. On 13Mar2021, the patient had not slept more than 1 to 2 hours without taking over the counter (OTC) sleep aid. It was also reported that, the patient did not feel tired but she never had sleeping issue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as result of events headache, neck ache included treatment with TYLENOL 1000mg at 03:00 and for sleep an OTC sleep aid. The clinical outcomes of events energy bursts, headache, neck ache and sleeplessness were not resolved at the time of this report.   No follow-up attempts are needed; no further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hypoaesthesia, SARS-CoV-2 test
Clinical narrative: Left side of face feels numb and warm; Left side of face feels numb and warm; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613), via an unspecified route of administration in the right arm on 25Mar2021 at 14:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, diabetic and overweight. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included pioglitazone (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab test on 21Mar2021 which included nasal swab and the test result was negative. On 25Mar2021 at 14:30, the patient's left side of face felt numb and warm. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events left side of face feels numb and warm. The clinical outcomes of the events left side of face feels numb and warm were unknown at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Myalgia, Paraesthesia oral, Swollen tongue
Clinical narrative: tongue slightly swollenand tingly; tongue slightly swollenand tingly; sweating; chills; Muscle aches; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: unknown), via an unspecified route of administration in the left arm on 22Mar2021 at 14:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EJ1685), via an unspecified route of administration in the left arm on 01Mar2021 at 14:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 24Mar2021 at 12:00, the patient experienced muscle aches, tongue slightly swollen and tingly, chills, and sweating. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient had not received any treatment for the events muscle aches, tongue slightly swollen and tingly, chills, and sweating. The clinical outcomes of muscle aches, tongue slightly swollen and tingly, chills, and sweating was resolved on an unknown date in Mar2021 at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain in extremity
Clinical narrative: sore arm; headache; fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 37-years-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown) via unspecified route of administration on left arm on 23Mar2021 at 15:00 PM (at the age of 37-years-old), as a single dose for COVID-19 immunisation. Medical history includes hypothyroidism. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 10:00 AM, the patient had experienced sore arm, headache and fatigue. The patient had not received any treatment for events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events for headache, fatigue, sore arm was recovered on an unknown date at the time of this report.    No follow-up attempts are possible. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, Viral test
Clinical narrative: Swollen lymph node armpit; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 22Mar2021 at 10:45 (at the age of 21-year-old) as single dose for COVID-19 immunisation. The medical history included covid-19 and no known allergies. The concomitant medications were not reported. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in 2021, the patient experienced swollen lymph node armpit. The patient underwent lab tests and procedures, which included nasal swab test on 23Mar2021 and the result was negative. The patient did not receive any treatment for the reported event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of lymphadenopathy axillary was recovering at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Pain, Pyrexia
Clinical narrative: Bodyache; Fatigue; Headache; Fever; Overall not feeling well; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE BIONTECH, Lot number: EP6955) via an unspecified route of administration in the right arm on 24Mar2021 at 13:30 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient was allergic to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE BIONTECH, Lot number: EN6198) via an unspecified route of administration in the left arm on 03Mar2021 at 14:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 24Mar2021 at 19:30, the patient experienced fatigue, headache, body ache, fever and overall not feeling well. The events did not result in doctor or other healthcare professional office/clinic visits, and the emergency room/department or urgent care. The patient did not receive any treatment for events. The clinical outcome of the events fatigue, headache, body ache, fever and overall not feeling well was recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dizziness, Headache, Nausea
Clinical narrative: Fever; Chills; Body aches; Pain at injection site; Headache; Nausea; Dizziness.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3247), via an unspecified route of administration in the left arm on 03Mar2021 at 11:30 (at the age of 42-years-old), as a single dose for COVID-19 immunisation and nitrofurantoin (MACROBID) on unknown date for unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Mar2021 at 01:30, the patient experienced fever, chills, body aches and pain at injection site with headache, nausea and dizziness. On 25Mar2021 at 01:30, the body temperature was reported as 101.3 (units unspecified). The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, chills, general body pain, vaccination site pain, nausea, headache and dizziness was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.